Summary
Excellus BlueCross BlueShield policy 7.02.07 covers liver transplantation for selected people with end-stage liver disease when criteria are met. Listed indications include alcoholic cirrhosis, viral hepatitis, autoimmune hepatitis, primary hepatocellular carcinoma when the disease is organ confined and the patient is not a candidate for subtotal liver resection, and familial amyloid polyneuropathy. Cadaver recipients need a MELD score of 9 or greater, and living donor recipients need a MELD score from 9 to 25, a listing on the cadaveric liver transplant waiting list, and at least one significant complication of liver disease. The current effective date is November 20, 2025, and the policy history records an annual review with the policy intent unchanged.
Get alerts when payers change rules like this one
We check Excellus BlueCross BlueShield and other payers every day and email you when a change matches your specialty and state.